← SynDRA
PF-04691502
SynDRA canonical compound SYN0024302 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PIK3CA |
|---|
| Mechanism of action | PI3K inhibitor |
|---|
All known targets
- MTOR
- PIK3CA
- PIK3CG
- PIK3CB
- PIK3CD
Mechanisms of action (all sources)
- MTOR inhibitor
- PI3K inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- MTOR MODULATOR
- PIK3CG MODULATOR
Cross-references
Synonyms
- PF-4691502
- PF 04691502
- UNII-4W39NS61KI
- 4W39NS61KI
- 2-amino-8-((1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one
- CHEMBL1234354
- PF04691502
- 2-Amino-8-[trans-4-(2-Hydroxyethoxy)cyclohexyl]-6-(6-Methoxypyridin-3-Yl)-4-Methylpyrido[2,3-D]pyrimidin-7(8h)-One
- 2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one
Look up PF-04691502 in the interactive SynDRA portal →